{"id":"https://openalex.org/W4402011968","doi":"https://doi.org/10.1080/10837450.2024.2398526","title":"A review on abuse-deterrent formulations: formulation technology and regulatory stands in approval process","display_name":"A review on abuse-deterrent formulations: formulation technology and regulatory stands in approval process","publication_year":2024,"publication_date":"2024-08-29","ids":{"openalex":"https://openalex.org/W4402011968","doi":"https://doi.org/10.1080/10837450.2024.2398526","pmid":"https://pubmed.ncbi.nlm.nih.gov/39206465"},"language":"en","primary_location":{"id":"doi:10.1080/10837450.2024.2398526","doi":"https://doi.org/10.1080/10837450.2024.2398526","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1080/10837450.2024.2398526","pdf_url":null,"source":{"id":"https://openalex.org/S80622011","display_name":"Pharmaceutical Development and Technology","issn_l":"1083-7450","issn":["1083-7450","1097-9867"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Development and Technology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106812416","display_name":"Jaydip Bhola","orcid":"https://orcid.org/0000-0002-4318-268X","observed_orcids":["https://orcid.org/0000-0002-4318-268X"]},"institutions":[{"id":"https://openalex.org/I29563240","display_name":"Gujarat Technological University","ror":"https://ror.org/059x8vm09","country_code":"IN","type":"education","lineage":["https://openalex.org/I29563240"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Jaydip Bhola","raw_affiliation_strings":["Department of Pharmaceutics, Gujarat Technological University, Ahmedabad, India"],"raw_orcid":"https://orcid.org/0000-0002-4318-268X","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Gujarat Technological University, Ahmedabad, India","institution_ids":["https://openalex.org/I29563240"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056982979","display_name":"Chetan H. Borkhataria","orcid":"https://orcid.org/0000-0001-9517-7578","observed_orcids":["https://orcid.org/0000-0001-9517-7578"]},"institutions":[{"id":"https://openalex.org/I4387153807","display_name":"B. K. Mody Government Pharmacy College","ror":"https://ror.org/00k7kt283","country_code":"IN","type":"education","lineage":["https://openalex.org/I4387153807"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Chetan Borkhataria","raw_affiliation_strings":["Department of Pharmaceutics, B. K. Mody Government Pharmacy College, Rajkot, India","B. K. Mody Government Pharmacy College, Polytechnic Campus, Rajkot, Gujarat, India"],"raw_orcid":"https://orcid.org/0000-0001-9517-7578","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, B. K. Mody Government Pharmacy College, Rajkot, India","institution_ids":["https://openalex.org/I4387153807"]},{"raw_affiliation_string":"B. K. Mody Government Pharmacy College, Polytechnic Campus, Rajkot, Gujarat, India","institution_ids":["https://openalex.org/I4387153807"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5056982979"],"corresponding_institution_ids":["https://openalex.org/I4387153807"],"apc_list":null,"apc_paid":null,"fwci":0.0643,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.16450274,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"29","issue":"8","first_page":"824","last_page":"831"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.011500000022351742,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abuse-deterrent-formulations","display_name":"abuse-deterrent formulations","score":0.9980000257492065},{"id":"https://openalex.org/keywords/opioid-abuse","display_name":"opioid abuse","score":0.8650000095367432},{"id":"https://openalex.org/keywords/prescription-opioid-overdose","display_name":"prescription opioid overdose","score":0.8100000023841858},{"id":"https://openalex.org/keywords/substance-abuse-prevention","display_name":"substance use prevention","score":0.5960000157356262},{"id":"https://openalex.org/keywords/poly-ethylene-oxide","display_name":"poly(ethylene oxide)","score":0.8220000267028809},{"id":"https://openalex.org/keywords/drug-formulation-technology","display_name":"drug formulation technology","score":0.5130000114440918},{"id":"https://openalex.org/keywords/regulatory-approval-process","display_name":"regulatory approval process","score":0.6539999842643738},{"id":"https://openalex.org/keywords/fda-guidance","display_name":"FDA guidance","score":0.8830000162124634},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5183125734329224},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.37626272439956665},{"id":"https://openalex.org/C55587333","wikidata":"https://www.wikidata.org/wiki/Q1133029","display_name":"Engineering ethics","level":1,"score":0.3357304036617279},{"id":"https://openalex.org/C190253527","wikidata":"https://www.wikidata.org/wiki/Q295354","display_name":"Law and economics","level":1,"score":0.3229556083679199},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.26552045345306396},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.22389930486679077},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.1964283287525177},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000075162","descriptor_name":"Abuse-Deterrent Formulations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/10837450.2024.2398526","doi":"https://doi.org/10.1080/10837450.2024.2398526","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1080/10837450.2024.2398526","pdf_url":null,"source":{"id":"https://openalex.org/S80622011","display_name":"Pharmaceutical Development and Technology","issn_l":"1083-7450","issn":["1083-7450","1097-9867"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Development and Technology","raw_type":"journal-article"},{"id":"pmid:39206465","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39206465","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical development and technology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"},{"id":"https://metadata.un.org/sdg/16","score":0.4399999976158142,"display_name":"Peace, justice, and strong institutions"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1973654032","https://openalex.org/W1978936941","https://openalex.org/W2023465185","https://openalex.org/W2027991723","https://openalex.org/W2032877010","https://openalex.org/W2075926301","https://openalex.org/W2114302216","https://openalex.org/W2208636851","https://openalex.org/W2417140602","https://openalex.org/W2526766920","https://openalex.org/W2583891203","https://openalex.org/W2747687728","https://openalex.org/W2894017677","https://openalex.org/W2939563034","https://openalex.org/W2994559045","https://openalex.org/W2996293268","https://openalex.org/W3136224103","https://openalex.org/W4281785524"],"related_works":["https://openalex.org/W2899922723","https://openalex.org/W4200303970","https://openalex.org/W2027991723","https://openalex.org/W4403058351","https://openalex.org/W2774766948","https://openalex.org/W2417140602","https://openalex.org/W2023146192","https://openalex.org/W2918074030","https://openalex.org/W4400299738","https://openalex.org/W2753337821"],"abstract_inverted_index":{"Drug":[0],"abuse":[1,14,79,141],"has":[2],"become":[3],"a":[4,100,182,188],"global":[5],"health":[6],"problem":[7],"over":[8],"the":[9,20,47,111,117,125,133,144,165,168],"past":[10],"few":[11,189],"years.":[12],"Opioid":[13],"increased":[15],"with":[16,55,107],"an":[17,172],"increase":[18],"in":[19,97,116],"prescription":[21,83],"of":[22,30,46,82,113,120,146,167,185],"opioids":[23],"for":[24],"pain":[25,60],"management.":[26],"Many":[27],"other":[28,203],"classes":[29],"drugs":[31],"are":[32,61,66,73],"also":[33],"abused":[34],"and":[35,42,58,80,110,132],"misused":[36],"like":[37],"anti-depressants,":[38],"stimulants,":[39],"hallucinogens,":[40],"anti-psychotic,":[41],"anticholinergic":[43],"drugs.":[44],"One":[45],"major":[48],"reasons":[49],"is":[50,199],"that":[51,129],"patients":[52],"falsely":[53],"diagnosed":[54],"depression,":[56],"anxiety,":[57],"severe":[59],"prescribed":[62],"these":[63],"drugs,":[64],"which":[65,158],"likely":[67],"to":[68,76,170,177,201],"be":[69],"addictive.":[70],"Abuse-deterrent":[71],"formulations":[72],"one":[74],"means":[75],"control":[77],"drug":[78,105,122,140,150],"overdose":[81],"opioids.":[84],"In":[85,124],"this":[86],"review,":[87],"we":[88],"explained":[89],"how":[90],"abuse-deterrent":[91,98,108,153],"technology":[92],"works,":[93],"key":[94],"ingredients":[95],"used":[96],"formulations,":[99],"brief":[101],"about":[102],"marketed":[103],"opioid":[104,121],"products":[106],"properties,":[109],"stand":[112],"regulatory":[114,183,190,204],"agencies":[115,191],"approval":[118],"process":[119,176],"products.":[123],"end,":[126],"it":[127],"summarized":[128],"pharmaceutical":[130],"industries":[131],"FDA":[134],"put":[135],"their":[136,194],"efforts":[137],"into":[138],"reducing":[139],"by":[142],"encouraging":[143],"development":[145],"ADFs.":[147,197],"Most":[148],"available":[149],"product":[151],"having":[152],"features":[154],"contains":[155],"Polyethylene":[156],"oxide,":[157],"degrades":[159],"at":[160],"high":[161],"temperatures.":[162],"It":[163,198],"requires":[164],"attention":[166],"researcher":[169],"find":[171],"alternate":[173],"ingredient":[174],"or":[175],"overcome":[178],"said":[179],"problem.":[180],"From":[181],"point":[184],"view,":[186],"only":[187],"have":[192],"published":[193],"guidance":[195],"on":[196,207],"important":[200],"convey":[202],"organizations'":[205],"perspectives":[206],"ADFs":[208],"as":[209],"well.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-08-30T00:00:00"}